Mankind Pharma files DRHP for Rs 5,500 crore IPO

19 Sep 2022 , 08:09 AM

Mankind Pharma, the drugmaker behind Manforce Condoms and Prega News, has filed its draft red herring prospectus (DRHP) for an initial public offering (IPO) with market regulator Sebi.

The size of the public offer is expected to be about Rs5,500 crore.

In the company’s initial public offering, the promoters and existing investors will sell 4 crore shares of equity.

JM Morgan, Citi, Jefferies, Axis, IIFL, and Kotak have been appointed as investment bankers by the business.

Prega News, an emergency contraceptive, Unwanted-21, AcneStar anti-bacterial gel, Ring out the anti-fungal powder, Gas-O-Fast, Kaloree 1 fake sweetener, Heal-O-Kind anti-bacterial ointment, Addiction Deodorant, and KabzEnd are some of the top over-the-counter (OTC) brands for males.

For feedback and suggestions, write to us at [e-mail]